etoposide has been researched along with Cystadenocarcinoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aalders, JG; Bouma, J; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH | 1 |
| Blessing, JA; Major, F; Manetta, A; Markman, M | 1 |
| Abfalter, E; Dapunt, O; Hetzel, H; Koza, A; Marth, C; Pointner, E; Windbichler, G; Zeimet, AG | 1 |
| Bardou, VJ; Bertucci, F; Delpero, JR; Faucher, C; Houvenaeghel, G; Maraninchi, D; Viens, P | 1 |
| Abfalter, E; Dapunt, O; Marth, C; Thaler, J; Zeimet, AG | 1 |
| Jimi, S; Tsuruchi, N | 1 |
| Fujita, H; Ito, R; Okada, H; Yamamoto, T | 1 |
| Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T | 1 |
| Cohen, CJ; Dottino, PR; Goodman, HM; Kredentser, D; Rosenberg, M | 1 |
| Barlow, JJ; Lele, SB | 1 |
| Jordaan, JP; Maxwell, AM | 1 |
| Grönroos, M; Kangas, L; Mäenpää, J | 1 |
| Bishop, JF; Campbell, JJ; Day, A; Hillcoat, BL; Pepperell, R; Quinn, MA | 1 |
2 trial(s) available for etoposide and Cystadenocarcinoma
| Article | Year |
|---|---|
Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Endometriosis; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Reoperation; Salvage Therapy; Treatment Outcome | 1993 |
Clinical trial of etoposide and cisplatin as salvage therapy in advanced ovarian carcinoma.
Topics: Adult; Aged; Carcinoma; Cisplatin; Clinical Trials as Topic; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms | 1987 |
11 other study(ies) available for etoposide and Cystadenocarcinoma
| Article | Year |
|---|---|
Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ovarian Neoplasms; Reoperation | 1984 |
[The value of etoposide (VP-16) in the therapy of refractory ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cause of Death; Cystadenocarcinoma; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate | 1993 |
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cystadenocarcinoma; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Laparotomy; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Autologous | 2000 |
Secondary leukaemias after etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Ovarian Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
[A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
Topics: Administration, Oral; Cystadenocarcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1992 |
[A case of recurrent ovarian cancer markedly responding to daily oral administration of low dose etoposide].
Topics: Administration, Oral; Aged; Cystadenocarcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Remission Induction | 1990 |
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma | 1990 |
Etoposide (VP-16) plus cisplatin (DDP): a new active chemotherapeutic combination in patients with stage III-IV ovarian adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Prognosis | 1986 |
Treatment for recurrent ovarian cancer. A report of 2 cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1987 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Methotrexate; Mice; Middle Aged; Mitomycins; Naphthacenes; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Vincristine | 1985 |
Phase II trial of VP-16-213 in advanced ovarian carcinoma.
Topics: Administration, Oral; Aged; Carcinoma; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting | 1985 |